References,Sample size,Interventions,Main race,Female (%),Mean HAMA,Mean age (Year),Attrition rate (%),Sponsor,Follow-up time (weeks),Diagnosis criteria
"Alaka et al., 2014",291,duloxetine: 30-120 mg/day,Caucasian,75.5,24.6,71.4,24,Eli Lilly and Company,10,dsm-iv
"Alaka et al., 2014",291,placebo,Caucasian,80.0,24.4,71.7,25,Eli Lilly and Company,10,dsm-iv
